Scavenger receptor of class B expressed by osteoblastic cells are implicated in the uptake of cholesteryl ester and estradiol from LDL and HDL3

Journal of Bone and Mineral Research

Volumn 23, Issue 3, 2008, Pages 326-337

  Brodeur, Mathieu R ^a   Brissette, Louise ^a   Falstrault, Louise ^a   Luangrath, Vilayphone ^a   Moreau, Robert ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Cholesteryl ester; Estradiol; High density lipoprotein; Low density lipoprotein; Osteoblast; Scavenger receptors; Selective uptake

Indexed keywords

CAVEOLIN; CD36 ANTIGEN; CHOLESTEROL ESTER; ESTRADIOL; HIGH DENSITY LIPOPROTEIN 3; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MEMBRANE LIPID; SCAVENGER RECEPTOR B; SCAVENGER RECEPTOR BI; SUCROSE; TRITIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE CELL; CELL CULTURE; CELL LINE; CELLULAR DISTRIBUTION; FRACTIONATION; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIPID DEGRADATION; LIPID METABOLISM; LIPID OXIDATION; LIPID TRANSPORT; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BONE REMODELING; CELL LINE; CHOLESTEROL ESTERS; ESTRADIOL; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, HDL3; LIPOPROTEINS, LDL; MICE; OSTEOBLASTS; SCAVENGER RECEPTORS, CLASS B;

EID: 39749173025     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.071022     Document Type: Article

References (65)

1. Jerome CP 2004 Hormonal therapies and osteoporosis. ILAR J 45:170-178.
2. Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD, Meunier PJ 1996 Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. J Clin Endocrinol Metab 81:1129-1133.
3. Frankenfeld CL, McTiernan A, Thomas WK, LaCroix K, McVarish L, Holt VL, Schwartz SM, Lampe JW 2006 Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Maturitas 53:315-324.
4. Sprague SM 2007 Renal function and risk of hip and vertebral fractures in older women: Is it always osteoporosis? Arch Intern Med 167:115-116.
5. De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP 2007 Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56:208-214.
6. Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV 1998 Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 62:209-213.
7. Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A 1997 Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 28:1730-1732.
8. Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y 1997 Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12:1438-1445.
9. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ 1977 HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 55:67-72.
10. Laroche M, Pouilles JM, Ribot C, Bendayan P, Bernard J, Boccalon H, Mazieres B 1994 Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 13:61-64.
11. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL 2001 Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 16:182-188.
12. Edwards CJ, Hart DJ, Spector TD 2000 Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355:2218-2219.
13. Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H 2000 Statin drugs and the risk of fracture. JAMA 284:1921-1922.
14. Schoofs MW, Sturkenboom MC, van der Klift M, Hofman A, Pols HA, Stricker BH 2004 HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res 19:1525-1530.
15. Rizzo M, Di Fede G, Mansueto P, Castello F, Carmina E, Rini GB 2004 Statins and osteoporosis: Myth or reality? Minerva Med 95:521-527.
16. Niemeier A, Kassem M, Toedter K, Wendt D, Ruether W, Beisiegel U, Heeren J 2004 Expression of LRP1 by human osteoblasts: A mechanism for the delivery of lipoproteins and vitamin K1 to bone. J Bone Miner Res 20:283-293.
17. Newman P, Bonello F, Wierzbicki AS, Lumb P, Savidge GF, Shearer MJ 2002 The uptake of lipoprotein-borne phylloquinone (vitamin K1) by osteoblasts and osteoblast-like cells: Role of heparan sulfate proteoglycans and apolipoprotein E. J Bone Miner Res 17:426-433.
18. Schilling AF, Schinke T, Munch C, Gebauer M, Niemeier A, Priemel M, Streichert T, Rueger JM, Amling M 2005 Increased bone formation in mice lacking apolipoprotein E. J Bone Miner Res 20:274-282.
19. Zhang J, Munger RG, West NA, Cutler DR, Wengreen HJ, Corcoran CD 2006 Antioxidant intake and risk of osteoporotic hip fracture in Utah: An effect modified by smoking status. Am J Epidemiol 163:9-17.
20. Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A 2003 Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study. J Clin Endocrinol Metab 88:1523-1527.
21. Turk C, Halici M, Guney A, Akgun H, Sahin V, Muhtaroglu S 2004 Promotion of fracture healing by vitamin E in rats. J Int Med Res 32:507-512.
22. Pan LC, Price PA 1985 The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. Proc Natl Acad Sci USA 82:6109-6113.
23. Tang M, Abplanalp W, Subbiah MT 1997 Association of estrogens with human plasma lipoproteins: Studies using estradiol-17b and its hydrophobic derivative. J Lab Clin Med 129:447-452.
24. Leszczynski DE, Schafer RM 1990 Nonspecific and metabolic interactions between steroid hormones and human plasma lipoproteins. Lipids 25:711-718.
25. Shwaery GT, Vita JA, Keaney JF 1997 Antioxidant protection of LDL by physiological concentrations of 17b-estradiol. Requirement for estradiol modification. Circulation 95:1378-1385.
26. Shwaery GT, Vita JA, Keaney JF 1998 Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-b-estradiol. Atherosclerosis 138:255-262.
27. Gong M, Wilson M, Kelly T, Su W, Dressman J, Kincer J, Matveev SV, Guo L, Guerin T, Li XA, Zhu W, Uittenbogaard A, Smart EJ 2003 HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 111:1579-1587.
28. Brown MS, Goldstein JL 1986 A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47.
29. Goldstein JL, Brown MS 1974 Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem 249:5153-5162.
30. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M 1996 Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518-520.
31. Brissette L, Charest MC, Falstrault L 1996 Selective uptake of cholesteryl esters of low-density lipoproteins is mediated by the lipoprotein-binding site in HepG2 cells and is followed by the hydrolysis of cholesteryl esters. Biochem J 318:841-847.
32. Green SR, Pittman RC 1991 Selective uptake of cholesteryl esters from low density lipoproteins in vitro and in vivo. J Lipid Res 32:667-678.
33. Rhainds D, Brodeur M, Lapointe J, Charpentier D, Falstrault L, Brissette L 2003 The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters. Biochemistry 42:7527-7538.
34. Swarnakar S, Temel RE, Connely MA, Azhar S, Williams DL 1999 Scavenger receptor class B, type I, mediates selective uptake of low density lipoprotein cholesteryl ester. J Biol Chem 274:29733-29739.
35. Rhainds D, Falstrault L, Tremblay C, Brissette L 1999 Uptake and fate of class B scavenger receptor ligands in HepG2 cells. Eur J Biochem 261:227-235.
36. Landschulz K, Pathak R, Rigotti A, Krieger M, Hobbs H 1996 Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest 98:984-995.
37. Yvan-Charvet L, Bobard A, Bossard P, Massiera F, Rousset X, Ailhaud G, Teboul M, Ferre P, Dagher G, Quignard-Boulange A 2007 In vivo evidence for a role of adipose tissue SR-BI in the nutritional and hormonal regulation of adiposity and cholesterol homeostasis. Arterioscler Thromb Vasc Biol 27:1340-1345.
38. Duong M, Collins HL, Jin W, Zanotti I, Favari E, Rothblat GH 2006 Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler Thromb Vasc Biol 26:541-547.
39. Calvo D, Gomez-Coronado D, Lasuncion MA, Vega MA 1997 CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified OxLDL and AcLDL) lipoprotein. Arterioscler Thromb Vasc Biol 17:2341-2349.
40. Brodeur MR, Luangrath V, Bourret G, Falstrault L, Brissette L 2005 Physiological importance of SR-BI in the in vivo metabolism of human HDL and LDL in male and female mice. J Lipid Res 46:687-696.
41. Out R, Hoekstra M, Spijkers JA, Kruijt JK, van Eck M, Bos IS, Twisk J, van Berkel TJ 2004 Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice. J Lipid Res 45:2088-2095.
42. Brundert MA, Ewert J, Heeren B, Behrendt R, Ramakrishnan H, Greten M, Merkel Rinninger F 2005 Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice. Arterioscler Thromb Vasc Biol 25:143-148.
43. Ji Y, Jian B, Wang N, Sun Y, de la Llera Moya M, Phillips MC, Rothblat GH, Swaney JB, Tall AR 1997 Scavenger receptor BI promotes high density lipoprotein mediated cellular cholesterol efflux. J Biol Chem 272:20982-20985.
44. Webb NR, Connell PM, Graf GA, Smart EJ, de Villiers WJ, de Beer FC, van der Westhuyzen DR 1998 SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem 273:15241-15248.
45. Connely MA, Klein SM, Azhar S, Abumrad NA, Williams DL 1999 Comparaison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J Biol Chem 274:41-47.
46. Gu X, Trigatti B, Xu S, Acton S, Babitt J, Krieger M 1998 The efficient cellular uptake of high density lipoprotein via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 273:984-995.
47. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa J, Kameda-Takemura K 1995 Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 96:1859-1865.
48. Podrez EA, Febbraio M, Sheibani N, Schmitt D, Silverstein RL, Hajjar DP, Cohen PA, Frazier WA, Hoff HF, Hazen SL 2000 Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest 105:1095-1108.
49. Langer T, Strober W, Levy RI 1972 The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest 51:1528-1536.
50. McFarlane AS 1948 Efficient trace-labelling of proteins with iodine. Nature 182:53-54.
51. Roberts DC, Miller NE, Price SG, Crook D, Cortese C, La Ville A, Masana L, Lewis B 1985 An alternative procedure for incorporating radiolabeled cholesteryl ester into human plasma lipoproteins in vitro. Biochem J 226:319-322.
52. Lougheed M, Steinbrecher UP 1996 Mechanism of uptake of copper-oxidized low density lipoprotein in macrophages is dependent on its extent of oxidation. J Biol Chem 271:11798-11805.
53. Scatchard G 1949 The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51:660-672.
54. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275.
55. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL 1997 Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680-687.
56. Mody N, Parhami F, Sarafian TA, Demer LL 2001 Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509-519.
57. Klein BY, Rojansky N, Ben-Yehuda A, Abou-Atta I, Abedat S, Friedman G 2003 Cell death in cultured human Saos2 osteoblasts exposed to low-density lipoprotein. J Cell Biochem 90:42-58.
58. Fu T, Kozarsky KF, Borensztajn J 2003 Overexpression of SR-BI by adenoviral vector reverses the fibrateinduced hypercholesterolemia of apolipoprotein E-deficient mice. J Biol Chem 278:52559-52563.
59. Out R, Kruijt JK, Rensen PC, Hildebrand RB, de Vos P, Van Eck M, Van Berkel TJ 2004 Scavenger receptor BI plays a role in facilitating chylomicron metabolism. J Biol Chem 279:18401-18416.
60. Out R, Hoekstra M, de Jager SC, de Vos P, van der Westhuyzen DR, Webb NR, Van Eck M, Biessen EA, Van Berkel TJ 2005 Adenovirus-mediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL/6J mice. J Lipid Res 46:1172-1181.
61. Hammond GL, Bocchinfuso WP 1995 Sex hormone-binding globulin/androgen- binding protein: Steroid-binding and dimerization domains. J Steroid Biochem Mol Biol 53:543-552.
62. Mendel CM 1989 The free hormone hypothesis: A physiologically based mathematical model. Endocr Rev 10:232-274.
63. Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N, Schulz H, Metzger J, Schweigert FJ, Luppa PB, Nykjaer A, Willnow TE 2005 Role of endocytosis in cellular uptake of sex steroids. Cell 122:751-762.
64. Lormeau C, Soudan B, d'Herbomez M, Pigny P, Duquesnoy B, Cortet B 2004 Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Bone 34:933-939.
65. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD 2000 Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 15:1526-1536.